Pre-BCR Signaling Pathway | Agammaglobulinemia скачать в хорошем качестве

Pre-BCR Signaling Pathway | Agammaglobulinemia

Welcome to our in-depth breakdown of the Pre-B Cell Receptor (Pre-BCR) signaling pathway, a crucial checkpoint in B cell development, and its direct connection to Agammaglobulinemia, a rare but serious immunodeficiency disease. In this video, we dissect the molecular signaling events, key protein players, and clinical implications of defects in this pathway. 📌 What You'll Learn in This Video: ✔️ What is the Pre-B Cell Receptor? ✔️ How the Pre-BCR initiates tonic and ligand-independent signaling ✔️ Role of signaling molecules like BLNK, BTK, SYK, PI3K, PKCβ, mTOR, and NF-κB ✔️ The checkpoint between Pro-B and Pre-B cell stages ✔️ Impact of Pre-BCR mutations on B cell maturation ✔️ Genetic and molecular basis of X-linked agammaglobulinemia (XLA) and other agammaglobulinemias ✔️ Symptoms and diagnostic markers of agammaglobulinemia ✔️ Current and emerging treatments 🔬 The Pre-BCR: A Critical Developmental Checkpoint The Pre-BCR is a unique surface receptor expressed transiently during early B cell development in the bone marrow. It consists of the µ heavy chain (μHC), surrogate light chains VpreB and λ5, and signal-transducing molecules Igα (CD79a) and Igβ (CD79b). This receptor complex is essential for: Testing successful heavy chain gene rearrangement Inducing proliferation of Pre-B cells Initiating allelic exclusion of the heavy chain gene Promoting light chain rearrangement Once assembled, the Pre-BCR clusters on the cell surface and activates downstream signaling cascades even in the absence of external antigens, a process termed tonic signaling. ⚙️ Molecular Signaling Pathway Overview When the Pre-BCR is formed, the following cascade is triggered: Activation of Src family kinases (e.g., LYN) Phosphorylation of ITAM motifs on Igα/Igβ Recruitment and activation of SYK (spleen tyrosine kinase) Activation of adaptor molecules like BLNK (B-cell linker protein) Recruitment of downstream effectors: BTK (Bruton's Tyrosine Kinase) PLCγ2 (phospholipase C gamma 2) Generation of IP3 and DAG Calcium influx and PKCβ activation Activation of pathways such as: NF-κB pathway → transcription of survival and proliferation genes PI3K/AKT/mTOR pathway → cell growth and metabolic regulation Each of these molecules plays a specific role in regulating cell fate, survival, and proliferation at this early stage of B cell development. ❌ When Things Go Wrong: Agammaglobulinemia Disruption in Pre-BCR signaling—due to mutations in key genes—can block B cell development, leading to Agammaglobulinemia, particularly X-linked agammaglobulinemia (XLA). 🧬 Key Genetic Mutations: BTK gene mutation (most common in XLA) BLNK, IGHM, IGLL1 (λ5), CD79A/CD79B mutations (seen in autosomal recessive forms) 🩺 Clinical Features of Agammaglobulinemia: Near-total absence of peripheral B cells (CD19+ B cells) Severely reduced serum IgG, IgA, and IgM Recurrent bacterial infections (sinopulmonary, gastrointestinal) Onset usually within the first year of life No or very few tonsils and lymph nodes Normal T cell function 🧪 Diagnosis: Flow cytometry for B cell count (CD19+) Serum immunoglobulin levels BTK protein expression by monocyte assay Genetic testing for BTK or related gene mutations 💉 Treatment: Regular intravenous or subcutaneous immunoglobulin (IVIG/SCIG) replacement Prompt antibiotics for infections Avoidance of live vaccines Genetic counseling for affected families Research into gene therapy is ongoing